End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.66 CNY | +0.79% | +2.61% | +14.69% |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.69% | 5.5B | D+ | ||
+73.46% | 12.41B | B- | ||
-15.61% | 8.23B | C+ | ||
+3.88% | 6.46B | C- | ||
-5.53% | 5.33B | B | ||
+42.58% | 5.1B | - | ||
-19.05% | 4.05B | B- | ||
-32.61% | 2.54B | C | ||
+10.80% | 1.99B | - | ||
-0.74% | 1.99B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 002223 Stock
- Ratings Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.